Premas Biotech, a developer of novel biotherapeutic and vaccine candidates announced that Oravax Medical Inc., a US based company that Premas Biotech is a partner in, has received clearance from the South African Health Products Regulatory Authority to commence patient enrollment in a first in human, Phase 1 clinical trial, for its oral COVID-19 vaccine; and preparations to begin the trials are now underway.
- Read more about Premas Biotech Announces Approval to Initiate Phase 1 Trials in South Africa, for Oravax's Oral Vaccine for COVID-19
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/premas-biotech-announces-approval-to-initiate-phase-1-trials-in-south-africa-for-oravaxs-oral-vaccine-for-covid-19
No comments:
Post a Comment